Rat Groups |
Group -1
(Normal saline treated rats) |
Group- 2
(Arthritic non - treated rats) |
Group-3 (Arthritic
Resvertrol - leflunamide treated rats) |
Group-4 (Arthritic Resvertrol treated rats) |
Group-5 (Arthritic leflunamide treated rats) |
Parameters |
Serum CRP
(mg/ml) |
3.86±0.13 |
12.85±1.14
*<0.05 |
5.12±0.43
#<0.05
**>0.05 |
7.65±0.85
#<0.05 |
6.15±0.85
#<0.05
*#>0.05 |
Serum MDA
(ng/ml) |
22.2 ± 3.00 |
85.78 ± 5.20
*<0.01 |
40.5 ± 3.38
#<0.05
**<0.05 |
55.0 ± 2.82
#<0.05 |
50.0 ± 3.82
#<0.05
*#>0.05 |
Serum MMP-3
(pg/ml) |
15.7 ± 3.00 |
55.30 ± 1.20
*<0.01 |
28.4 ± 3.90
#<0.05
**<0.05 |
39.0 ± 2.50
#<0.05 |
35.0 ± 3.70
#<0.05
*#> 0.05 |
SerumPGE2
(pg/ml) |
12.5 ± 2.00 |
105.3 ± 4.20
*<0.01 |
35.5 ± 3.60
#<0.01
**<0.05 |
45.3 ± 3.30
#<0.01 |
41.2 ± 4.90
#<0.01
*#>0.05 |
Serum TNF-α
(pg/ml) |
0.010 ± 0.30 |
90.2 ± 4.80
*<0.001 |
40.15 ± 3.40
#<0.01
**<0.05 |
52.11 ± 4.17
#<0.05 |
45.33 ± 5.22
#<0.05
*#<0.05 |
SerumIL-6
(pg/ml) |
27.5 ± 3.20 |
225.2 ± 2.20
*<0.001 |
95.2 ± 3.20
#<0.01
**<0.05 |
120.0 ± 4.10
#<0.01 |
110.0 ± 2.70
#<0.01
*#<0.05 |
p-value using one-way ANOVA followed by Bonferroni multiple comparison test as a post ANOVA test.